News
Inquiry
Contact Us for business opportunity
Recruitment information
Japanese
HOME
Vision
Vision
Introducing the vision SymBio Pharmaceuticals.
CEO message
SymBio in 2 minutes
Corporate culture
Charter of Corporate Behavior
Book introduction
Business model
Business model
I would like to introduce the business model of SymBio Pharmaceuticals.
Business domain and profit model
Proprietary drug discovery business
Global business
Joint research with academia
Key person interview
Pipeline
Pipeline
We would like to introduce the pipeline of SymBio Pharmaceuticals.
Pipeline overview
SyB V-1901
SyB L-0501
SyB L-1101/C-1101
IR information
IR information
Aiming for patient-centered, mutually supportive relationships among scientists, doctors, governments, and shareholders.
Latest IR information
IR news
CEO message
Financial highlights
IR library
Analyst report
Video library
IR Calendar
General Meeting of Shareholders Information
Basic stock information
Electronic public notice
About SymBio
About SymBio
Company Information of SymBio Pharmaceuticals
Company Profile
Origin of company name
History
Officer introduction
Organization chart
Corporate
governance
Compliance
about
on transparency
Information disclosure
SDGs initiatives
News
Inquiry
Recruitment of new drug information
Recruitment information
Japanese
TOP
IR Information
臨時報告書・有価証券届出書 (Japanese Only) - IR library
IR library
Summary of Financial Results
Business Results
株主通信 (Japanese Only)
有価証券報告書・四半期報告書 (Japanese Only)
臨時報告書・有価証券届出書 (Japanese Only)
Annual Report
その他IR資料 (Japanese Only)
臨時報告書・有価証券届出書 (Japanese Only)
PDF形式のファイルをご覧になるためにはAdobe Readerが必要です。
Adobe Readerをお持ちでない場合は、左のアイコンからダウンロードして下さい。